AT THE FOREFRONT OF
INNOVATION
Dive into a world where boundaries fade and possibilities are limitless.
Discover the future, where the human experience and digital innovation converge.
FGP CAPITAL
AT THE FOREFRONT OF
INNOVATION
Dive into a world where boundaries fade and possibilities are limitless.
Discover the future, where the human experience and digital innovation converge.
FGP CAPITAL
AT THE FOREFRONT OF
INNOVATION
Dive into a world where boundaries fade and possibilities are limitless.
Discover the future, where the human experience and digital innovation converge.
FGP CAPITAL
0{{current_slide_index}} | 0{{total_slide_count}}
Our main focus are:
Past transaction from cutting edge academic research to successful IPO on the London Stock Exchange:
pushing the boundaries of science and changing the world for the better
We help finance clinical research and development in the following indications
Emerging evidence of potential brake through in anti-cancer treats
Portfolio of PDI inhibitors and new innate immune pathway modulators
Next-generation anti-thrombotics
Potential key player in sickle-cell disease, hight risk cardiac and stroke patients
Patented next generation form factor redefining the industry
Next generation therapeutic and prophylactic treatments
Clinical trials are the vital bridge between scientific discovery and real-world application.
AND RISKS ASSESSMENT
arrow_forward Late-stage
arrow_forward Sweet spot of high growth companies soon becoming cash flow positive and ready for a trade sale or an IPO
arrow_forward Low valuations of European and Swiss private Companies vs US peers
arrow_forward High probabilities of multiple 3-15x exits within 1-3/5 years
arrow_forward Disruptive technologies / IP portfolio of strategic relevance to key industry players
(big pharma, medtech, security / defence…)
arrow_forward Deep knowledge of underlying technologies and how to achieve shareholder value creation
arrow_forward Long-term involvement with top management
arrow_forward Selective Board seats
arrow_forward Different levers of value creation, including active involvement in ongoing and upcoming M&A activities
arrow_forward Different levers of downside protection
arrow_forward No exposure to the economic cycle
arrow_forward Privileged access to world-class Research Institutes and University spin-offs
arrow_forward Global network of industry experts, scientists and KOL involved in sourcing deals, nurturing and exiting investments
arrow_forward Focus on growth capital deals in healthcare
arrow_forward Target short-medium holding periods with an average 3-year exit strategy through IPOs or trade sales
arrow_forward Active in M&A transactions
Typical structures include straight equities and convertible bonds
PHILANTHROPY
SUPPORTED MUSICIANS
Contacts
Philippe Froehlicher
+30 years of experience in portfolio management and capital markets. +10 years of experience in private equity.
In 2009, he co-founded FGP Capital. His responsibilities include the strategic development of the firm. Philippe oversees asset allocation and investment decisions. Prior to 2009, Philippe ran discretionary global mandates for HNWI at Pictet & Cie since 1998.
Philippe has studied with world famous professors in corporate strategy, including Michael Porter (Harvard) and Klaus Schwab (World Economic Forum). He holds a Master in Business Administration & Economics from the University of Geneva, where he specialized in finance and corporate strategy.
Richard Ormond
+35 years of investment experience in fund, portfolio and client management. +10 years of experience in private equity
His expertise has expanded from traditional investments to private equity and debt investments in growth capital for life science, technology and consumer companies.
Prior to joining the Group in 2012, Richard spent 22 years as client and fund manager (Small Caps and Emerging Markets) with Pictet & Cie. Richard holds a Master in Business & Management and completed his studies with a postgraduate Diploma in Economics & Finance from the University of Geneva.
For wealth management, financial advisory, please contact
Mr. Rene Grand
at BOCCARD FINANCE SA, Geneva, Switzerland, a FINMA regulated entity:
+ 41 22 908 01 88 / rene.grand@boccardfinance.ch
© 2025 FGP CAPITAL
Geneva, Switzerland
7, Rue des Alpes
1201 Genève
Switzerland
info@fgpcapital.com
+41 (0) 22 753 53 53